Glaxo CEO Says World Will Need More Than One Covid-19 Vaccine

The transcript discusses the efforts of GSK and Sanofi in developing a vaccine through a partnership. It highlights the importance of scaling production to meet global demand and the need for multiple vaccines. The discussion includes plans for global manufacturing and equitable distribution, emphasizing the importance of access for both developed and developing countries. The transcript also touches on responsible pricing and collaboration with governments and institutions to ensure widespread vaccine availability.

What is the primary goal of the partnership between the two major companies in vaccine development?

• To focus on a single market

• To reduce the cost of vaccines

• To scale production and protect more people

• To create a new type of vaccine

Which regions are expected to be involved in the manufacturing of the vaccine?

• Only the United States

• Only Europe

• The US, Europe, and potentially the UK

• Only developing countries

What is a key consideration in the global distribution of vaccines?

• Focusing solely on developed countries

• Ensuring access for both developed and developing economies

• Ignoring vulnerable healthcare systems

• Manufacturing in a single location

How does the company plan to support equitable access to vaccines?

• By focusing only on private institutions

• By donating a certain volume of vaccines

• By limiting distribution to certain countries

• By increasing prices in developed markets

What role do global governments play in the vaccine distribution strategy?

• They will set high prices for vaccines

• They will only focus on their own countries

• They are expected to support access and delivery

• They are not involved